Дмитренко, І. В. “Prognostic Value of Early Reduction of BCR/ABL1 Gene Expression in Criteria of Deep Molecular Response on Imatynib Therapy in Patients With Chronic Myeloid Leukemia”. Problems of Environmental Biotechnology, no. 1 (June 27, 2018). Accessed June 14, 2026. http://jrnl.kai.edu.ua/index.php/ecobiotech/article/view/12851.